BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26026287)

  • 21. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells.
    Tomita M; Hayashi M; Awazu S
    J Pharm Sci; 1996 Jun; 85(6):608-11. PubMed ID: 8773957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of synergistic permeation enhancers for oral drug delivery.
    Whitehead K; Karr N; Mitragotri S
    J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.
    Maher S; Wang X; Bzik V; McClean S; Brayden DJ
    Eur J Pharm Sci; 2009 Nov; 38(4):301-11. PubMed ID: 19664704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport.
    Datta P; Weis MT
    World J Gastroenterol; 2015 Aug; 21(30):9055-66. PubMed ID: 26290632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Otagiri M
    J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
    Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
    Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difructose anhydride III and sodium caprate activate paracellular transport via different intracellular events in Caco-2 cells.
    Suzuki T; Hara H
    Life Sci; 2006 Jun; 79(4):401-10. PubMed ID: 16566947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
    McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
    J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons.
    Shimazaki T; Tomita M; Sadahiro S; Hayashi M; Awazu S
    Dig Dis Sci; 1998 Mar; 43(3):641-5. PubMed ID: 9539662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
    Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
    J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
    Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
    Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.
    Cox AB; Rawlinson LA; Baird AW; Bzik V; Brayden DJ
    Pharm Res; 2008 Jan; 25(1):114-22. PubMed ID: 17546408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
    Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
    Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
    Bzik VA; Brayden DJ
    Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate.
    Sugibayashi K; Onuki Y; Takayama K
    Eur J Pharm Sci; 2009 Feb; 36(2-3):246-53. PubMed ID: 19013238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
    Lapointe TK; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
    Makhlof A; Werle M; Tozuka Y; Takeuchi H
    J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.
    Brayden DJ; Gleeson J; Walsh EG
    Eur J Pharm Biopharm; 2014 Nov; 88(3):830-39. PubMed ID: 25460147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.